2025-09-14 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc. (UNH) based on the data you provided. The report is structured with numerical data upfront, followed by analysis and commentary.

**Report on UnitedHealth Group Inc. (UNH)**

**Company Overview:** UnitedHealth Group Inc. is a diversified health care company operating primarily in the United States.

**1. Performance vs. S&P 500 (VOO)**

*   **UNH Cumulative Return:** 12.44%
*   **VOO Cumulative Return:** 89.18%
*   **Absolute Deviation:** The data's cumulative return for UNH is significantly lower than the S&P 500 (VOO).
*   **Relative Deviation:** 22.4 (This places the current deviation in the lower end of its historical range compared to VOO.)
*   **Deviation Range:** Max: 362.5, Min: -68.8, Current: 27.9

**Alpha/Beta Analysis Table & Interpretation:**

| Year       | CAGR    | MDD   | Alpha  | Beta | Cap(B) |
|------------|---------|-------|--------|------|--------|
| 2015-2017  | -1.0%   | 1.0%  | -4.0%  | -1.2 | 199.7  |
| 2016-2018  | 0.0%    | 63.4% | 4.0%   | 0.1  | 225.6  |
| 2017-2019  | 21.0%   | 63.4% | -2.0%  | 0.0  | 266.2  |
| 2018-2020  | 7.0%    | 63.4% | -20.0% | 0.1  | 317.6  |
| 2019-2021  | 43.0%   | 60.6% | -6.0%  | 0.2  | 454.8  |
| 2020-2022  | 32.0%   | 66.6% | 26.0%  | 0.5  | 480.2  |
| 2021-2023  | 33.0%   | 67.5% | 13.0%  | 0.5  | 476.8  |
| 2022-2024  | -19.0%  | 68.7% | -46.0% | 0.3  | 458.1  |
| 2023-2025  | -28.0%  | 75.5% | -83.0% | 0.0  | 319.3  |

*   **CAGR:**  Fluctuating, with negative values in the most recent periods (2022-2025).
*   **MDD:** Maximum Drawdown is consistently high, indicating significant potential for price declines from peak values.
*   **Alpha:**  Inconsistent alpha generation, with significant negative alpha in recent periods, particularly the most recent (2023-2025). This suggests UNH has significantly underperformed relative to its risk (Beta).
*   **Beta:** Beta values are generally low, suggesting UNH is less sensitive to market movements than the S&P 500.
*   **Cap(B):** Market Cap data shows significant growth, peaking in 2020-2022 but declining recently.

**2. Recent Price Movement**

*   **Current Price:** 352.51
*   **Previous Close:** 353.61
*   **Price Change:** -0.31
*   **5-Day Moving Average:** 344.214
*   **20-Day Moving Average:** 315.4325
*   **60-Day Moving Average:** 294.535

*   **Analysis:** The stock price is slightly down from the previous close. The 5-day moving average is above the 20-day and 60-day moving averages, and the 20-day is above the 60-day, suggesting a recent upward trend.

**3. Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3233 (Low Risk)
*   **RSI:** 79.676 (Overbought)
*   **PPO:** 1.5177
*   **Hybrid Signal:** Buy 80% of cash (3 shares - Caution - MRI:0.34) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Recent Delta Relative Divergence Change:** 8.7 (+) (Short-term increase)
*   **Expected Return:** 884.7% (Long-term, relative to S&P 500)

*   **Analysis:**
    *   The MRI indicates low market risk.
    *   The RSI is in overbought territory, suggesting the stock may be due for a correction.
    *   The Hybrid Signal suggests a cautious buying approach.
    *   The increase in relative divergence indicates a recent short-term upward trend.
    *   The extraordinarily high expected return should be viewed with skepticism. Such high projections are rare and may be based on overly optimistic assumptions.

**4. Recent News & Significant Events**

*   **UnitedHealth sought to meet Trump, WSJ reports:** This headline suggests potential policy implications and lobbying efforts that could affect the company.
*   **UnitedHealth Is Spending Big on Trump Allies to Fix Its Washington Problems:** Reinforces the lobbying narrative and potential regulatory challenges.
*   **These Were the 3 Top-Performing Stocks in the S&P 500 in August 2025:** Positive sentiment.
*   **Investing.com’s stocks of the week:** Indicates inclusion in a potentially positive list.
*   **2 Dirt Cheap Stocks to Buy With $5,000 Right Now:** Indicates UNH is a good stock to buy
*   **Warren Buffett's Berkshire Hathaway Just Revealed More Than a Billion Dollars in New Investments -- and This Steel-Manufacturer Is on the Short List:** Indicates UNH is a good stock to buy

*   **Analysis:** The news headlines present a mixed picture. The political engagement and lobbying efforts could be seen as a risk or opportunity, depending on the outcomes. Being highlighted as a top-performing stock and included in investment lists is positive.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.96)
*   **Opinions:** 24 analysts
*   **Target Price:** Avg: 338.33 / High: 626.00 / Low: 198.00
*   **Recent Rating Changes:** Not specified (→ )

*   **Analysis:** Analyst consensus is positive (Buy), but the wide range in target prices indicates uncertainty about the stock's future value. The average target price is *below* the current price, which is a concern.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-08-11 | 3.76 | 111.62 B$  |
| 2025-05-07 | 6.9  | 109.58 B$  |
| 2024-11-04 | 6.56 | 100.82 B$  |
| 2024-08-09 | 4.58 | 98.86 B$  |
| 2025-08-11 | 4.58 | 98.86 B$  |

*   **Analysis:** Revenue has been generally increasing, but EPS has fluctuated. The most recent EPS figure (3.76) is lower than previous quarters, even with higher revenue.

**6. Financial Information**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-06-30   | $111.62B    | 17.93%        |
| 2025-03-31   | $109.58B    | 21.70%        |
| 2024-12-31   | $100.81B    | 21.14%        |
| 2024-09-30   | $100.82B    | 22.84%        |
| 2024-06-30   | $98.86B     | 22.31%        |

| Quarter      | Equity      | ROE    |
|--------------|-------------|--------|
| 2025-06-30   | $94.72B    | 3.60%  |
| 2025-03-31   | $95.04B    | 6.62%  |
| 2024-12-31   | $92.66B    | 5.98%  |
| 2024-09-30   | $94.53B    | 6.41%  |
| 2024-06-30   | $89.36B    | 4.72%  |

*   **Analysis:**
    *   **Revenue:** Shows a clear upward trend.
    *   **Profit Margin:** Decreasing in the most recent quarter.  This coincides with the lower EPS in the earnings data.
    *   **Equity:** Relatively stable.
    *   **ROE:**  Decreased significantly in the most recent quarter, reflecting the lower profitability.

**7. Overall Summary & Considerations**

*   **Performance:** UNH has significantly underperformed the S&P 500 recently, as reflected in the cumulative return difference and recent negative alpha.
*   **Technicals:**  The stock is currently in overbought territory (RSI), suggesting a potential pullback. However, moving averages indicate a recent upward trend.
*   **Financials:** Revenue is growing, but profitability (profit margin and ROE) is declining, which is a concern.  The recent EPS figures also reflect this.
*   **Analyst Opinion:**  Analyst consensus is "Buy," but the average target price is *below* the current price, indicating that analysts, on average, don't see much upside potential.
*   **News:** News headlines are mixed, with potential political risks and some positive mentions in investment lists.
*   **Expected Return:**  The stated expected return of 884.7% is highly unlikely and should be treated with extreme caution.

**Overall Assessment:**

UNH appears to be facing some challenges. While revenue continues to grow, declining profitability and underperformance relative to the S&P 500 are concerning. The overbought RSI and analyst target prices below the current price suggest limited short-term upside potential. Investors should carefully consider these factors and the political/regulatory risks highlighted in the news before making investment decisions. The extremely high expected return figure should not be relied upon.
